<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Merial acquires Hyonate anti-inflammatory for horses</title><link>/b/veterinary-news/posts/133270</link><description> Merial Animal Health has announced that it has purchased the the anti-inflammatory treatment for lameness in horses, Hyonate&amp;#174; (sodium hyaluronate), from Bayer. 
 Merial&amp;#39;s equine marketing and technical manager, Louise Radford MRCVS said: &amp;quot;Hyonate is</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>